Detalhe da pesquisa
1.
Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
J Biol Chem
; 290(35): 21305-19, 2015 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26160169
2.
Elucidation of the Burkholderia cenocepacia hopanoid biosynthesis pathway uncovers functions for conserved proteins in hopanoid-producing bacteria.
Environ Microbiol
; 17(3): 735-50, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24888970
3.
Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in Burkholderia cenocepacia().
Mol Microbiol
; 85(5): 962-74, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22742453
4.
The Burkholderia cenocepacia sensor kinase hybrid AtsR is a global regulator modulating quorum-sensing signalling.
Environ Microbiol
; 15(2): 372-85, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22830644
5.
The Achromobacter type 3 secretion system drives pyroptosis and immunopathology via independent activation of NLRC4 and NLRP3 inflammasomes.
Cell Rep
; 42(8): 113012, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598340
6.
Perception of the Impact of Artificial Intelligence in the Decision-Making Processes of Public Healthcare Professionals.
J Environ Public Health
; 2022: 8028275, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35874877
7.
Hyperspectral Image Analysis of Colon Tissue and Deep Learning for Characterization of Health care.
J Environ Public Health
; 2022: 8670534, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35685861
8.
Adaptation and antibiotic tolerance of anaerobic Burkholderia pseudomallei.
Antimicrob Agents Chemother
; 55(7): 3313-23, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21537012
9.
Systematic Review and Meta-analysis of Herpes Zoster Vaccine in Patients With CKD.
Kidney Int Rep
; 6(5): 1254-1264, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34013103
10.
Drug development post COVID-19 pandemic: toward a better system to meet current and future global health challenges.
Expert Opin Drug Discov
; 16(4): 365-371, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356641
11.
Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay.
Appl Environ Microbiol
; 76(10): 3170-6, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20348312
12.
Roles of YopN, LcrG and LcrV in controlling Yops secretion by Yersinia pestis.
Adv Exp Med Biol
; 603: 225-34, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17966419
13.
A markerless deletion method for genetic manipulation of Burkholderia cenocepacia and other multidrug-resistant gram-negative bacteria.
Methods Mol Biol
; 1197: 311-27, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25172289
14.
Structural-functional studies of Burkholderia cenocepacia D-glycero-ß-D-manno-heptose 7-phosphate kinase (HldA) and characterization of inhibitors with antibiotic adjuvant and antivirulence properties.
J Med Chem
; 56(4): 1405-17, 2013 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23256532
15.
An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei.
Gene
; 430(1-2): 123-31, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19010402
16.
Structure-function analysis of the C-terminal domain of LcrV from Yersinia pestis.
J Bacteriol
; 189(18): 6734-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17644582